1. Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3
   Li Lin et al, 2017, CBM CrossRef
2. Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia
   Yu-Yi Chu et al, 2017, Cell Death Dis CrossRef
3. G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis
   L. F. F. Bittencourt et al, 2019, J Neurooncol CrossRef
4. Long non‐coding RNA TNRC6C‐AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway
   Xinzhi Peng et al, 2019, J Cell Mol Med CrossRef
5. null
   Christian R. Gomez, 2019 CrossRef
6. From Supramolecular Hydrogels to Multifunctional Carriers for Biologically Active Substances
   Joanna Skopinska-Wisniewska et al, 2021, IJMS CrossRef
7. Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
   Ying Zhang et al, 2021, BMC Cancer CrossRef
8. Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis
   Xue Liu et al, 2022, Front. Oncol. CrossRef
9. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation
   Dechao Feng et al, 2022, Heliyon CrossRef
10. Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer
    Kalliopi Zafeiropoulou et al, 2024, PLoS ONE CrossRef
11. Bortezomib in cancer therapy: Mechanisms, side effects, and future proteasome inhibitors
    Olusola Sogbein et al, 2024, Life Sciences CrossRef